Ask AI

Search

Loading...

Table of contents

Sick sinus syndrome

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of sick sinus syndrome are prepared by our editorial team based on guidelines from the Heart Rhythm Society (HRS 2022), the Japanese Heart Rhythm Society (JHRS/JCS 2022,2021), the European Society of Cardiology (ESC 2021,2018), the Infectious Diseases Society of America (IDSA/ACR/AAN 2021), the American Heart Association (AHA 2020), the American Heart ...
Show more

Diagnostic investigations

History and physical examination: as per ACC/AHA/HRS 2019 guidelines, elicit a comprehensive history and perform a physical examination in patients with suspected bradycardia.
B
Create free account

More topics in this section

  • Resting ECG

  • Exercise ECG

  • Ambulatory ECG monitoring

  • Diagnostic imaging

  • Laboratory testing

  • Sleep evaluation

Diagnostic procedures

Implantable loop recorder: as per ESC 2021 guidelines, obtain long-term ambulatory monitoring with an implantable loop recorder in patients with infrequent (< 1 per month) unexplained syncope or other symptoms suspected to be caused by bradycardia, if the initial comprehensive evaluation is nondiagnostic.
A

More topics in this section

  • Electrophysiology study

Medical management

Shared decision-making: as per ACC/AHA/HRS 2019 guidelines, engage patients with symptomatic bradycardia in a shared decision-making process for treatment decisions and base treatment decisions on the best available evidence and the patient's goals of care, preferences, and values.
B

More topics in this section

  • Addressing reversible causes

  • Atropine

  • Beta-adrenergic agonists

  • Theophylline and aminophilline

  • PDE3 inhibitors

Therapeutic procedures

Temporary pacing, transvenous: as per ESC 2021 guidelines, perform temporary transvenous pacing in patients with hemodynamic-compromising bradyarrhythmia refractory to IV chronotropic drugs.
B
Show 3 more

More topics in this section

  • Temporary pacing (transcutaneous)

  • Permanent pacing (indications, asymptomatic bradycardia)

  • Permanent pacing (indications, symptomatic bradycardia)

  • Permanent pacing (shared decision-making)

  • Permanent pacing (pre-implantation assessment)

  • Permanent pacing (peri-implantation care)

  • Permanent pacing (choice of leads)

  • Permanent pacing (singl- versus dual-chamber pacing)

  • Permanent pacing (septum pacing)

  • Permanent pacing (CRT)

  • Permanent pacing (remote monitoring)

  • Permanent pacing (considerations for MRI)

  • Permanent pacing (discontinuation)

Perioperative care

Prophylactic perioperative pacing: as per ACC/AHA/HRS 2019 guidelines, consider placing transcutaneous pacing pads in patients deemed at high risk for the development of intraoperative or periprocedural bradycardia because of patient characteristics or procedure type.
C
Show 2 more

Specific circumstances

Patients with beta-blocker toxicity
As per ACC/AHA/HRS 2019 guidelines:
Consider administering glucagon to increase HR and improve symptoms in patients with bradycardia associated with symptoms or hemodynamic compromise caused by β-blocker overdose.
C
Consider administering high-dose insulin to increase HR and improve symptoms in patients with bradycardia associated with symptoms or hemodynamic compromise caused by β-blocker overdose.
C

More topics in this section

  • Patients with CCB toxicity

  • Patients with digoxin toxicity

  • Patients with tachycardia-bradycardia syndrome (permanent pacing)

  • Patients with tachycardia-bradycardia syndrome (AF ablation)

  • Patients with acute myocardial infarction

  • Patients with Lyme carditis

  • Patients with congenital heart disease

  • Patients after cardiac surgery

  • Patients after heart transplantation

  • Patients with obstructive sleep apnea

  • Patients with accidental hypothermia

  • Patients with acute spinal cord injury

  • Patients with neuromuscular disorders